Traditional consensus holds that hospitals are ill-suited to the healthcare priorities in Africa countries whose policies must focused mainly on promoting primary services. Indeed hospitals are generally considered as inefficient and wasteful of financial resources that could be used for more important healthcare priorities. Long excluded from major development programs, most hospital facilities have gone from crisis to crisis over the last 10 years and are now unable to provide adequate services. The sometimes dramatic state of these institutions raises serious doubt not only about the effectiveness of current healthcare policies but also about the long-term survival of the healthcare systems now being established. But this situation is not the result of fate but rather of the failure of public hospitals to adapt their organization to the realities of today's world. Indeed hospital services are provided within a purely administrative structure with total disregard for the principles of good management. A new vision for revival of healthcare systems make hospitals a key component in a network of healthcare institutions and recommends that they be included in an in-depth reform of healthcare systems that consider any healthcare act as a service in the "economic" sense of the word and its availability as the end-result of a production process. To ensure fulfillment of the public service mission of the hospital, the resulting "entrepreneurial" approach must be accompanied by appropriation of subsidies so that charges are affordable to a majority of the population, implementation of welfare programs to insure that even the poorest users have sufficient resources, and development of monitoring capabilities.
Download full-text PDF |
Source |
---|
Med J Aust
January 2025
Juno Healthcare, Melbourne, VIC.
BMC Chem
January 2025
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Nile Valley University (NVU), El Fayoum, 63518, Egypt.
Coronavirus disease 2019 (COVID-19), an extremely contagious illness, has posed enormous challenges to healthcare systems around the world. Although the evidence on COVID-19 management is growing, antiviral medication is still the first line of treatment. Therefore, it is critical that effective, safe, and tolerable antivirals be available to treat early COVID-19 and stop its progression.
View Article and Find Full Text PDFBMC Health Serv Res
January 2025
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Background: The role of hospital pharmacists in managing cell and gene therapy (CGT) and advanced therapy medicinal products (ATMPs) is gradually being recognized but the evidence about impact of their role has not been systematically reported.
Objective: This study was aimed to summarize the professional services provided by hospital pharmacists on managing CGT/ATMPs and the evidence about the effects on patient care, as well as to identify the perceptions about pharmacists assuming a role that supports the appropriate and safe use of CGT/ATMPs.
Methods: Literature from 4 electronic databases (PubMed, ScienceDirect, Web of Science, Scopus) were searched following PRISMA checklist to yield publications on the interventions provided by hospital pharmacists in the management of CGT/ATMPs dated since 1 January 2013 till 30 April 2023.
BMC Gastroenterol
January 2025
Department of Gastroenterology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, Szczecin, 71-254, Poland.
Background: Functional gastrointestinal disorders (FGIDs), now known as disorders of gut-brain interaction (DGBIs), such as Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD), significantly impact global health, reducing quality of life and burdening healthcare systems. This study addresses the epidemiological gap in Poland, focusing on the West Pomeranian Voivodeship.
Methods: We conducted a cross-sectional study of 2070 Caucasian patients (58.
BMC Geriatr
January 2025
James P. Wilmot Cancer Institute, Rochester, New York, USA.
Background: Older adults with cancer are vulnerable to declines in muscle performance (e.g., strength, speed, duration of muscular contraction), which are associated with worse cancer-related outcomes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!